How has been the historical performance of Indoco Remedies?

Answer:The historical performance of Indoco Remedies shows a fluctuating trend in key financial metrics over the years.

Breakdown:
Indoco Remedies' net sales peaked at 1,817.29 Cr in March 2024 but fell to 1,664.92 Cr in March 2025. The total operating income followed a similar pattern, decreasing from 1,817.29 Cr in March 2024 to 1,664.92 Cr in March 2025. The operating profit (PBDIT) also declined significantly from 254.16 Cr in March 2024 to 104.71 Cr in March 2025, indicating a drop in profitability. This decline was accompanied by an increase in total expenditure, which remained relatively stable at around 1,565.66 Cr in March 2025 compared to 1,572.98 Cr in March 2024. Consequently, the profit before tax turned negative at -74.37 Cr in March 2025, down from 135.80 Cr in March 2024, leading to a profit after tax of -77.95 Cr in March 2025. The company's total assets grew from 2,144.73 Cr in March 2024 to 2,429.91 Cr in March 2025, while total liabilities also increased from 2,144.73 Cr to 2,429.91 Cr in the same period. Cash flow from operating activities decreased to 94.00 Cr in March 2025 from 155.00 Cr in March 2024, and the net cash outflow was recorded at -2.00 Cr in March 2025. Overall, the financial performance of Indoco Remedies reflects challenges in maintaining profitability despite growth in total assets and liabilities.